Abstract
BackgroundComputed tomography (CT) is commonly used in all stages of oesophageal squamous cell carcinoma (SCC) management. Compared to basic CT features, CT radiomic features can objectively obtain more information about intratumour heterogeneity. Although CT radiomics has been proved useful for predicting treatment response to chemoradiotherapy in oesophageal cancer, the best way to use CT radiomic biomarkers as predictive markers for determining resectability of oesophageal SCC remains to be developed. This study aimed to develop CT radiomic features related to resectability of oesophageal SCC with five predictive models and to determine the most predictive model.MethodsFive hundred ninety-one patients with oesophageal SCC undergoing contrast-enhanced CT were enrolled in this study, and were composed by 270 resectable cases and 321 unresectable cases. Of the 270 resectable oesophageal SCCs, 91 cases were primary resectable tumours; and the remained 179 cases received neoadjuvant therapy after CT, shrank on therapy, and changed to resectable tumours. Four hundred thirteen oesophageal SCCs including 189 resectable cancers and 224 unresectable cancers were randomly allocated to the training cohort; and 178 oesophageal SCCs including 81 resectable tumours and 97 unresectable tumours were allocated to the validation group. Four hundred ninety-five radiomic features were extracted from CT data for identifying resectability of oesophageal SCC. Useful radiomic features were generated by dimension reduction using least absolute shrinkage and selection operator. The optimal radiomic features were chosen using multivariable logistic regression, random forest, support vector machine, X-Gradient boost and decision tree classifiers. Discriminating performance was assessed with area under receiver operating characteristic curve (AUC), accuracy and F-1score.ResultsEight radiomic features were selected to create radiomic models related to resectability of oesophageal SCC (P-values < 0.01 for both cohorts). Multivariable logistic regression model showed the best performance (AUC = 0.92 ± 0.04 and 0.87 ± 0.02, accuracy = 0.87 and 0.86, and F-1score = 0.93 and 0.86 in training and validation cohorts, respectively) in comparison with any other model (P-value < 0.001). Good calibration was observed for multivariable logistic regression model.ConclusionCT radiomic models could help predict resectability of oesophageal SCC, and multivariable logistic regression model is the most predictive model.
Highlights
Computed tomography (CT) is commonly used in all stages of oesophageal squamous cell carcinoma (SCC) management
According to the National Comprehensive Cancer Network (NCCN) based on CT scans [14], the criteria for unresectable oesophageal cancer were as follows: (1) cT4b tumours with involvement of the heart, great vessels, trachea, or adjacent organs including liver, pancreas, lung and spleen were considered unresectable; (2) oesophageal SCC with multi-station bulky lymphadenopathy was considered unresectable, lymph node involvement should be considered in conjunction with other factors including age and performance status and response to therapy; or (3) oesophageal SCC with distant metastases including nonregional lymph nodes was unresectable
Patients were enrolled into our study according to the following inclusion criteria: (a) the patients did not receive any tumour-related treatments before undergoing CT for both resectable and unresectable oesophageal SCC groups; and (b) oesophageal SCC was regarded unresectable and resectable according to the previous NCCN guidelines based on CT findings
Summary
Computed tomography (CT) is commonly used in all stages of oesophageal squamous cell carcinoma (SCC) management. CT radiomics has been proved useful for predicting treatment response to chemoradiotherapy in oesophageal cancer, the best way to use CT radiomic biomarkers as predictive markers for determining resectability of oesophageal SCC remains to be developed. This study aimed to develop CT radiomic features related to resectability of oesophageal SCC with five predictive models and to determine the most predictive model. The major histological type of this cancer is squamous cell carcinoma (SCC) [2]. Patients with advanced oesophageal SCC (Stage T3 and T4a) may undergo neoadjuvant chemoradiotherapy before surgical resection. The option of the most suitable treatment has a remarkable effect on the prognosis of patients with oesophageal SCC. It is crucial to determine resectability of oesophageal SCC for treatment decision making
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.